BackSpringWorks Therapeutics Overview

SpringWorks Therapeutics Current Cash

Latest current cash for SWTX: $64M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$63.77M
↓ 45.97% YoYΔ $-54.26M vs prior year quarter

Peer average

Loading

SpringWorks Therapeutics Current Cash History

Loading

SpringWorks Therapeutics vs. peers: Current Cash Comparison

Loading

SpringWorks Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

SpringWorks Therapeutics (SWTX) FAQ

SpringWorks Therapeutics (SWTX) currently reports a current cash of $64M as of March 2025. That compares with $120M in the prior-year period — down 46.0% year over year. Use the charts on this page to explore SpringWorks Therapeutics's current cash history and peer comparisons.

SpringWorks Therapeutics's current cash decreased from $120M to $64M — a 46.0% year-over-year decrease (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

SpringWorks Therapeutics reported $64M in current cash as of March 2025. That compares with $120M in the prior-year period — down 46.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $64M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for SpringWorks Therapeutics, and consider following SWTX for alerts when major investors trade the stock.

SpringWorks Therapeutics is classified in the Healthcare sector. On current cash, it currently shows $64M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SWTX with unrelated industries.